Indianapolis, IN, United States of America

Cora Sue Grossman


Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1990-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Cora Sue Grossman: Innovations in Antineoplastic Agents

Introduction

Cora Sue Grossman is an accomplished inventor based in Indianapolis, Indiana, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of six patents, her work primarily focuses on the development of antineoplastic and antitumor agents, paving the way for new treatment options in oncology.

Latest Patents

Cora Sue Grossman's latest innovations include two notable patents:

1. **Thiophene-and thiazolesulfonamides as antineoplastic agents** - This invention provides antineoplastic compounds formulated to combat various types of cancer, offering potential new avenues for treatment.

2. **Benzoylsulfonamides and sulfonylbenzamidines for use as antitumor agents** - This patent highlights the creation of antitumor compounds designed to inhibit tumor growth, showcasing Grossman's dedication to advancing cancer therapies.

Career Highlights

Cora Sue Grossman is currently employed at Eli Lilly and Company, a leading global pharmaceutical company renowned for its innovative healthcare solutions. Throughout her career, Grossman has demonstrated exceptional expertise in her field, contributing to the development of life-saving medications that address critical health challenges faced by patients worldwide.

Collaborations

In her quest for innovation, Cora Sue Grossman has worked alongside esteemed colleagues, including Karen Lynn Lobb and Philip Arthur Hipskind. This collaborative approach has allowed her to leverage insights and expertise, driving forward the research and development of novel therapeutic agents.

Conclusion

Cora Sue Grossman's impressive array of patents and her role at Eli Lilly and Company underscore her significance in the pharmaceutical industry. Through her groundbreaking work on antineoplastic and antitumor agents, she continues to impact the lives of patients battling cancer, embodying the spirit of innovation and dedication essential to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…